entertainment -WSS

entertainment

author：entertainment 2025-09-06 03:32:53 - browse：299

Private Medicare just isn’t the gold mine it once was. Case in point: Cano Health, a company once valued at $4.4 billion, is now bankrupt.

The prospect of bankruptcy had stalked the Miami-based primary care provider for well over a year before its Chapter 11 filing on Sunday. A number of things had gone wrong. First, there was Cano’s rapid growth ahead of its 2021 initial public offering that gave way to a mountain of debt, currently sitting at $1.3 billion. Then there was public beef between its former directors and then-CEO.

Most importantly, the company’s main business, Medicare Advantage, became less profitable. As evidence accumulated that the private insurers running MA plans game the system by exaggerating their members’ illnesses, the Biden administration vowed to fix the problem. This year, Medicare is phasing in a new payment model designed to reduce overpayment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： UnitedHealth’s Optum accused of antitrust violations in California

WSS

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Diagnostic tests are hitting their mathematical limits

The EPA's new lead rule: How one expert crunched the numbers

Pediatric cancer treatments threatened by a new FDA policy

UpToDate has a racism problem: Dr. Stanley Goldfarb

hotspot

entertainment

focus

Peter Hotez and the public health issue of online harassment

U.K. Biobank has 500,000 peoples' genome sequences available

After affirmative action ruling, medical educators look to 'holistic review'

BIO selects John Crowley as new CEO

Medicare details structure of new drug price negotiation program

UpToDate has a racism problem: Dr. Stanley Goldfarb

Psychedelics group wrestles with new pharma identity

Use doctors trained outside the U.S. to ease the physician shortage

Dobbs anniversary: the lost opportunity of abortion as health care

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

focus

AstraZeneca lung cancer study comes in below expectations

As biotech industry slumps, bioscience job market is upside down

The wait for US passports is creating travel purgatory and snarling summer plans

UnitedHealth’s Optum accused of antitrust violations in California

With clinical trial data readouts, here's how to spot spin

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Wikipedia

Wikipedia

hotspot

focus